SREBF2 and prostate cancer: Studies demonstrated that miR-185 significantly reduced the levels of both full-length and mature SREBP2 proteins in liver cancer and prostate cancer cells by binding to the 3′untranslated region (3′UTR) of SREBP2 mRNA (Li et al., 2013; Yang et al., 2014; Chen et al., 2021).